Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

Spotlight AQ Randomized Controlled Trial of the Spotlight AQ Survey Platform to Evaluate Its' Efficacy and Applicability in a Clinic Setting.

The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care (SOC) pre-clinic assessment in adolescents & young adults (16-25 years old) with Type 1 Diabetes (T1D).

The main questions it aims to answer are:

• Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it?
• Do patients and healthcare providers like using the spotlight AQ survey?

Participants will use the Spotlight AQ survey before coming in to two standard of care T1D clinic visits Participants will fill out surveys describing how they feel about using the Spotlight AQ survey. Some participants may be asked to do an interview to talk about how they feel about the Spotlight AQ survey.

Inclusion Criteria:

• 16-25 years old
• Patients diagnosed with T1D for at least 6 months
• On any diabetes treatment
• Using a Continuous Glucose Monitor (CGM)
• Willing/ able to use Spotlight AQ tool
• Able to give verbal assent
• Patients & parents/caregiver speak English/ Spanish fluently
• Patients in the Children's Mercy Kansas City Hospital or Boston Children's Hospital network

Exclusion Criteria:

• <16 years old or >25 years old
• Mental illness that could seriously reduce their ability to participate in the study
• Lack of capacity
• In another T1D intervention study